Expression and function of osteopontin in vascular adventitial fibroblasts and pathological vascular remodeling

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Jin, Xin ^b,c,d   Fu, Guo xiang ^a,c   Li, Xiao dong ^b,c   Zhu, Ding liang ^a,c   Gao, Ping jin ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chinese Academy of Sciences   (China)

^c Shanghai Institute of Hypertension   (China)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ANTISENSE OLIGONUCLEOTIDE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOPONTIN; TRANSCRIPTION FACTOR AP 1; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTISENSE OLIGODEOXYNUCLEOTIDE; FLAVONOID; VASOCONSTRICTOR AGENT;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CAROTID ARTERY INJURY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVITY; FIBROBLAST; MALE; MOLECULAR PATHOLOGY; NEOINTIMA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CAROTID ARTERY; CELL CULTURE; CELL MOTION; CONNECTIVE TISSUE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; THORACIC AORTA; WESTERN BLOTTING;

RATTUS;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELLS, CULTURED; CONNECTIVE TISSUE; FIBROBLASTS; FLAVONOIDS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTOR AP-1; VASOCONSTRICTOR AGENTS;

EID: 80052888797     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023558     Document Type: Article

References (62)

1. Beck GR Jr, Knecht N, (2003) Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 278: 41921-41929.
2. Malaval L, Wade-Gueye NM, Boudiffa M, Fei J, Zirngibl R, et al. (2008) Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205: 1145-1153.
3. Shinohara ML, Jansson M, Hwang ES, Werneck MB, Glimcher LH, et al. (2005) T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc Natl Acad Sci U S A 102: 17101-17106.
4. Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, et al. (2009) Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest 119: 1583-1594.
5. Kohan M, Breuer R, Berkman N, (2009) Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. Am J Respir Cell Mol Biol 41: 290-296.
6. Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG, (2010) The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 48: 504-511.
7. Lund SA, Giachelli CM, Scatena M, (2009) The role of osteopontin in inflammatory processes. J Cell Commun Signal 3: 311-322.
8. Fu K, Corbley MJ, Sun L, Friedman JE, Shan F, et al. (2008) SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. Arterioscler Thromb Vasc Biol 28: 665-671.
9. Haurani MJ, Pagano PJ, (2007) Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease? Cardiovasc Res 75: 679-689.
10. House SJ, Singer HA, (2008) CaMKII-delta isoform regulation of neointima formation after vascular injury. Arterioscler Thromb Vasc Biol 28: 441-447.
11. Short M, Nemenoff RA, Zawada WM, Stenmark KR, Das M, (2004) Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. Am J Physiol Cell Physiol 286: C416-425.
12. Li L, Zhu DL, Shen WL, Gao PJ, (2006) Increased migration of vascular adventitial fibroblasts from spontaneously hypertensive rats. Hypertens Res 29: 95-103.
13. Siow RC, Churchman AT, (2007) Adventitial growth factor signalling and vascular remodelling: potential of perivascular gene transfer from the outside-in. Cardiovasc Res 75: 659-668.
14. Gao PJ, Li Y, Sun AJ, Liu JJ, Ji KD, et al. (2003) Differentiation of vascular myofibroblasts induced by transforming growth factor-beta1 requires the involvement of protein kinase Calpha. J Mol Cell Cardiol 35: 1105-1112.
15. Jin X, Ge X, Zhu DL, Yan C, Chu YF, et al. (2007) Expression and function of vascular endothelial growth factor receptors (Flt-1 and Flk-1) in vascular adventitial fibroblasts. J Mol Cell Cardiol 43: 292-300.
16. Sun AJ, Gao PJ, Liu JJ, Ji KD, Zhu DL, (2004) [Osteopontin enhances migratory ability of cultured aortic adventitial fibroblasts from spontaneously hypertensive rats]. Sheng Li Xue Bao 56: 21-24.
17. Touyz RM, Tabet F, Schiffrin EL, (2003) Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol 30: 860-866.
18. Struthers AD, (2004) The clinical implications of aldosterone escape in congestive heart failure. Eur J Heart Fail 6: 539-545.
19. Shen WL, Gao PJ, Che ZQ, Ji KD, Yin M, et al. (2006) NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem Biophys Res Commun 339: 337-343.
20. Giry J, Safwate A, Barlet JP, (1985) Control of aldosterone secretion in domestic mammals during the perinatal period. Reprod Nutr Dev 25: 993-1005.
21. Spat A, Hunyady L, (2004) Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84: 489-539.
22. Canfield AE, Farrington C, Dziobon MD, Boot-Handford RP, Heagerty AM, et al. (2002) The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J Pathol 196: 228-234.
23. Chaulet H, Desgranges C, Renault MA, Dupuch F, Ezan G, et al. (2001) Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res 89: 772-778.
24. Irita J, Okura T, Kurata M, Miyoshi K, Fukuoka T, et al. (2008) Osteopontin in rat renal fibroblasts: functional properties and transcriptional regulation by aldosterone. Hypertension 51: 507-513.
25. Isoda K, Nishikawa K, Kamezawa Y, Yoshida M, Kusuhara M, et al. (2002) Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 91: 77-82.
26. Jalvy S, Renault MA, Lam Shang Leen L, Belloc I, Reynaud A, et al. (2007) CREB mediates UTP-directed arterial smooth muscle cell migration and expression of the chemotactic protein osteopontin via its interaction with activator protein-1 sites. Circ Res 100: 1292-1299.
27. Leen LL, Filipe C, Billon A, Garmy-Susini B, Jalvy S, et al. (2008) Estrogen-stimulated endothelial repair requires osteopontin. Arterioscler Thromb Vasc Biol 28: 2131-2136.
28. Panda D, Kundu GC, Lee BI, Peri A, Fohl D, et al. (1997) Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci U S A 94: 9308-9313.
29. Sodhi CP, Batlle D, Sahai A, (2000) Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK. Kidney Int 58: 691-700.
30. Nitschke Y, Hartmann S, Torsello G, Horstmann R, Seifarth H, et al. (2009) Expression of NPP1 is regulated during atheromatous plaque calcification. J Cell Mol Med.
31. Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, et al. (2000) Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol 20: 624-628.
32. Abe K, Nakashima H, Ishida M, Miho N, Sawano M, et al. (2008) Angiotensin II-induced osteopontin expression in vascular smooth muscle cells involves Gq/11, Ras, ERK, Src and Ets-1. Hypertens Res 31: 987-998.
33. Renault MA, Jalvy S, Potier M, Belloc I, Genot E, et al. (2005) UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J Biol Chem 280: 2708-2713.
34. Xie Z, Pimental DR, Lohan S, Vasertriger A, Pligavko C, et al. (2001) Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species. J Cell Physiol 188: 132-138.
35. Xie Z, Singh M, Singh K, (2004) ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J Cell Physiol 198: 399-407.
36. Davie NJ, Gerasimovskaya EV, Hofmeister SE, Richman AP, Jones PL, et al. (2006) Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1. Am J Pathol 168: 1793-1807.
37. Mallawaarachchi CM, Weissberg PL, Siow RC, (2005) Smad7 gene transfer attenuates adventitial cell migration and vascular remodeling after balloon injury. Arterioscler Thromb Vasc Biol 25: 1383-1387.
38. Stenmark KR, Davie N, Frid M, Gerasimovskaya E, Das M, (2006) Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda) 21: 134-145.
39. Torsney E, Hu Y, Xu Q, (2005) Adventitial progenitor cells contribute to arteriosclerosis. Trends Cardiovasc Med 15: 64-68.
40. Chen W, Chu Y, Zhu D, Yan C, Liu J, et al. (2009) Perivascular gene transfer of dominant-negative N19RhoA attenuates neointimal formation via inhibition of TGF-beta1-Smad2 signaling in rats after carotid artery balloon injury. Biochem Biophys Res Commun 389: 217-223.
41. Hilberg F, Aguzzi A, Howells N, Wagner EF, (1993) c-jun is essential for normal mouse development and hepatogenesis. Nature 365: 179-181.
42. Jin X, Song X, Li L, Wang Z, Tao Y, et al. (2007) Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma. Mol Carcinog 46: 901-911.
43. Jochum W, Passegue E, Wagner EF, (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20: 2401-2412.
44. Sharma HS, van Heugten HA, Goedbloed MA, Verdouw PD, Lamers JM, (1994) Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts. Biochem Biophys Res Commun 205: 105-112.
45. Chen W, Bowden GT, (1999) Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes. Oncogene 18: 7469-7476.
46. Chen W, Dong Z, Valcic S, Timmermann BN, Bowden GT, (1999) Inhibition of ultraviolet B--induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol Carcinog 24: 79-84.
47. Collins AR, Schnee J, Wang W, Kim S, Fishbein MC, et al. (2004) Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. J Am Coll Cardiol 43: 1698-1705.
48. Alessandri G, Girelli M, Taccagni G, Colombo A, Nicosia R, et al. (2001) Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab Invest 81: 875-885.
49. Campagnolo P, Cesselli D, Al Haj Zen A, Beltrami AP, Krankel N, et al. (2010) Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 121: 1735-1745.
50. Corselli M, Chen CW, Crisan M, Lazzari L, Peault B, (2010) Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol 30: 1104-1109.
51. Hoshino A, Chiba H, Nagai K, Ishii G, Ochiai A, (2008) Human vascular adventitial fibroblasts contain mesenchymal stem/progenitor cells. Biochem Biophys Res Commun 368: 305-310.
52. Hu Y, Xu Q, (2011) Adventitial biology: differentiation and function. Arterioscler Thromb Vasc Biol 31: 1523-1529.
53. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, et al. (2004) Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 113: 1258-1265.
54. Majesky MW, Dong XR, Hoglund V, Mahoney WM Jr, Daum G, (2011) The adventitia: a dynamic interface containing resident progenitor cells. Arterioscler Thromb Vasc Biol 31: 1530-1539.
55. Passman JN, Dong XR, Wu SP, Maguire CT, Hogan KA, et al. (2008) A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc Natl Acad Sci U S A 105: 9349-9354.
56. Torsney E, Xu Q, (2011) Resident vascular progenitor cells. J Mol Cell Cardiol 50: 304-311.
57. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
58. Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ, et al. (2011) Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis 32: 477-487.
59. Wang Y, Yan W, Lu X, Qian C, Zhang J, et al. (2011) Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avbeta3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells. Eur J Cell Biol 90: 642-648.
60. Yu M, Liu Q, Yi K, Wu L, Tan X, (2011) Effects of osteopontin on functional activity of late endothelial progenitor cells. J Cell Biochem 112: 1730-1736.
61. Marche P, Herembert T, Zhu DL, (1995) Molecular mechanisms of vascular hypertrophy in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol Suppl 22: S114-116.
62. Zhu DL, Herembert T, Marche P, (1991) Increased proliferation of adventitial fibroblasts from spontaneously hypertensive rat aorta. J Hypertens 9: 1161-1168.